WVE
Wave Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$4.86
+3.40%Aug 10, 2026, 12:30 UTC
Wave Life Sciences completed its redomiciliation from a Singapore company to a Delaware corporation via a scheme of arrangement under Singapore law.
Source:Jul 30, 2026, 00:00 UTC
Wave Life Sciences Ltd. reported financial results for the second quarter of 2026, with total revenue of $2.3 million and a net loss of $69.4 million.
Source:Jul 7, 2026, 20:15 UTC
Wave Life Sciences announced that it has obtained shareholder approval for its redomiciliation to the United States via a scheme of arrangement, which is subject to a Singapore Court hearing on July 14, 2026.
Source: